Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Deaths in gene therapy of Duchenne muscular dystrophy and other diseases: Underlying mechanisms and mitigating strategies.

Molecular therapy : the journal of the American Society of Gene Therapy·2026
Same author

Canine Model of Duchenne Muscular Dystrophy.

Methods in molecular biology (Clifton, N.J.)·2025
Same author

DWORF expression is reduced in a large animal model of Duchenne muscular dystrophy.

Disease models & mechanisms·2025
Same author

Circulatory CCL2 distinguishes Duchenne muscular dystrophy dogs.

Disease models & mechanisms·2025
Same author

[High mobility group protein B1(HMGB1) promotes myeloid dendritic cell maturation and increases Th17 cell/Treg cell ratio in patients with immune primary thrombocytopenia].

Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology·2025
Same author

Adeno-Associated Virus 8 and 9 Myofibre Type/Size Tropism Profiling Reveals Therapeutic Effect of Microdystrophin in Canines.

Journal of cachexia, sarcopenia and muscle·2025

相关实验视频

Updated: Jul 13, 2025

Direct Intrathecal Injection of Recombinant Adeno-associated Viruses in Adult Mice
08:17

Direct Intrathecal Injection of Recombinant Adeno-associated Viruses in Adult Mice

Published on: February 15, 2019

37.2K

在高剂量全身AAV治疗中致命的免疫毒性.

Dongsheng Duan1

  • 1Department of Molecular Microbiology and Immunology and Department of Neurology, School of Medicine, Department of Biomedical Sciences, College of Veterinary Medicine, Department of Chemical and Biomedical Engineering, College of Engineering, University of Missouri, Columbia, MO 65212, USA.

Molecular therapy : the journal of the American Society of Gene Therapy
|October 12, 2023
PubMed
概括

使用腺相关病毒 (AAV) 的高剂量全身基因疗法显示出有前途,但可能导致致命的免疫反应. 为了了解和预防AAV诱导的免疫毒性,进一步的研究对患者安全至关重要.

关键词:
在 AAV AAV AAV 中.在 ARDS 中,ARDS 是指 ARDS 的类型.克里斯普尔是什么意思?克里斯普尔是什么意思?在 DMD DMD 里面,你会发现杜申尼肌肉发育不良症是什么急性呼吸困扰综合征是什么腺相关病毒的病毒.死亡死亡死亡死亡死亡死亡免疫毒性 免疫毒性天生的免疫反应.系统性基因治疗.

更多相关视频

A Step-By-Step Method to Detect Neutralizing Antibodies Against AAV using a Colorimetric Cell-Based Assay
05:53

A Step-By-Step Method to Detect Neutralizing Antibodies Against AAV using a Colorimetric Cell-Based Assay

Published on: December 7, 2021

4.6K
Author Spotlight: Developing Gene Therapies for Muscular Dystrophies and Neuromuscular Disorders
05:03

Author Spotlight: Developing Gene Therapies for Muscular Dystrophies and Neuromuscular Disorders

Published on: August 23, 2024

1.4K

相关实验视频

Last Updated: Jul 13, 2025

Direct Intrathecal Injection of Recombinant Adeno-associated Viruses in Adult Mice
08:17

Direct Intrathecal Injection of Recombinant Adeno-associated Viruses in Adult Mice

Published on: February 15, 2019

37.2K
A Step-By-Step Method to Detect Neutralizing Antibodies Against AAV using a Colorimetric Cell-Based Assay
05:53

A Step-By-Step Method to Detect Neutralizing Antibodies Against AAV using a Colorimetric Cell-Based Assay

Published on: December 7, 2021

4.6K
Author Spotlight: Developing Gene Therapies for Muscular Dystrophies and Neuromuscular Disorders
05:03

Author Spotlight: Developing Gene Therapies for Muscular Dystrophies and Neuromuscular Disorders

Published on: August 23, 2024

1.4K

科学领域:

  • 免疫学 免疫学 免疫学
  • 遗传学 是一个遗传学.
  • 药理学 药理学是指药理学的学科.

背景情况:

  • 使用腺相关病毒 (AAV) 进行全身基因疗法正在研究遗传性疾病.
  • 虽然在一些疾病 (如脊髓肌肉缩) 中成功,但高剂量的AAV疗法导致了器官衰竭的死亡.
  • 对AAV载体和宿主因子的免疫反应与这种毒性有关.

研究的目的:

  • 审查与高剂量全身AAV基因治疗中的死亡相关的临床发现.
  • 突出免疫毒性在AAV基因疗法相关不良事件中的作用.
  • 倡导合作努力,以阐明和减轻AAV诱导的致死性.

主要方法:

  • 对临床试验数据和关于系统性AAV基因治疗的出版文献的审查.
  • 分析报告的不良事件,重点关注死亡和器官衰竭.
  • 检查导致载体毒性的免疫机制.

主要成果:

  • 在高剂量全身AAV基因疗法后,由于肝脏,脏,心脏或肺部衰竭而导致死亡.
  • 对AAV载体的先天性和适应性免疫反应是毒性的关键决定因素.
  • 患者特定的宿主因素也会导致严重不良事件的风险.

结论:

  • 了解AAV诱导的免疫毒性机制对于改善患者安全至关重要.
  • 研究人员,临床医生和监管机构需要共同努力,制定预防和治疗策略.
  • 缓解免疫反应是实现系统性AAV基因治疗在遗传性疾病中的全部潜力的关键.